Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges.
Advances in antiretroviral therapy for human immunodeficiency virus (HIV)-infected pregnant women have improved maternal health and successfully reduced perinatal transmission from 25% to less than 5%. Maternal treatment is individualized and based on physical and laboratory evaluations. Three categ...
| Publicado en: | Journal of Perinatal & Neonatal Nursing Vol. 16; no. 2; pp. 1 - 26 |
|---|---|
| Autor principal: | |
| Formato: | pictorial practice guidelines review tables/charts Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
Sep2002
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106982886&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106982886 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08932190 0O1 jtl: Journal of Perinatal & Neonatal Nursing issn: 08932190 maglogo: N pubinfo: dt: Sep2002 vid: 16 iid: 2 pid: 5086 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 106982886 106982886 2002160264 10.1097/00005237-200209000-00003 NLM12233942 106982886 ppf: 1 ppct: 25 formats: fmt: @attributes: type: P tig: atl: Antiretroviral therapy in HIV-infected pregnant women and their infants: current interventions and challenges. aug: au: Shannon M affil: Certified Nurse-Midwife and Family Nurse Practitioner, Women's Specialty Clinic and Perinatal HIV Program, University of California, San Francisco, San Francisco, CA sug: subj: Infant, Newborn, Diseases Prevention and Control Anti-HIV Agents In Pregnancy Antiviral Agents Administration and Dosage Antiviral Agents Administration and Dosage Disease Transmission, Vertical Prevention and Control United States HIV Infections Epidemiology HIV Infections Physiopathology Drug Therapy, Combination Disease Progression Diagnosis Disease Progression Prevention and Control Research Human Immunodeficiency Virus Physiology Immune System United States Food and Drug Administration Practice Guidelines Antiviral Agents Pharmacodynamics Zidovudine Protease Inhibitors Prenatal Care Intrapartum Care Postnatal Care Infant, Newborn Infant Pregnancy Female Infant, Newborn: birth-1 month Infant: 1-23 months Female ab: Advances in antiretroviral therapy for human immunodeficiency virus (HIV)-infected pregnant women have improved maternal health and successfully reduced perinatal transmission from 25% to less than 5%. Maternal treatment is individualized and based on physical and laboratory evaluations. Three categories of drugs are currently approved for use in HIV disease including: (11 nucleoside and nucleotide reverse transcriptase inhibitors; (2) non-nucleoside reverse transcriptase inhibitors; and (3) protease inhibitors. Treatment decisions during pregnancy are complex and require consideration of the physiologic changes of pregnancy, drug interactions, possible maternal and fetal side effects, and psychosocial issues that influence adherence to the chosen therapy. Copyright © 2002 by Aspen Publishers, Inc. pubtype: Academic Journal doctype: pictorial practice guidelines review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|